SCHEMBL10061560

SCHEMBL10061560

CCCc1cccc(C(F)(F)F)c1C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.40
IDO1 P14902 2/20 0.39
HSD11B1 P28845 1/20 0.38
NR1H2 P55055 1/20 0.36
NR1H3 Q13133 1/20 0.36
SLC6A2 P23975 3/20 0.36
SLC6A4 P31645 3/20 0.36
CACNA1C Q13936 1/20 0.36
SCN5A Q14524 1/20 0.36
CTSK P43235 2/20 0.35
CTSS P25774 1/20 0.35
LMNA P02545 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PTPN1 P18031 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRB2 P47870 1/20 0.34
MAOB P27338 1/20 0.34
POLQ O75417 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22864099 0.87 LIPG (0.42) HSD11B1SLC6A2SLC6A4
SCHEMBL21312967 0.84 GABRA1 (0.46) ARIDO1HSD11B1SLC6A2SLC6A4
SCHEMBL327569 0.82 IDO1 (0.52) ARIDO1SLC6A2SLC6A4CTSK
SCHEMBL13256371 0.81 GRM5 (0.36) ARGABRA1GABRB2
SCHEMBL27254254 0.81 SLC6A4 (0.40) ARNR1H2NR1H3SLC6A2SLC6A4
SCHEMBL6957784 0.81 IDO1 (0.39) IDO1HSD11B1MAOBPOLQ
SCHEMBL13551083 0.81 EPHX2 (0.40) ARIDO1NR1H2NR1H3SLC6A2
SCHEMBL18124487 0.81 AR (0.40) ARIDO1NR1H2NR1H3SLC6A2
SCHEMBL25089766 0.79 P2RX7 (0.46) SLC6A2SLC6A4CTSKCTSS
SCHEMBL22427773 0.79 AR (0.39) ARIDO1NR1H2NR1H3SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120022040-A1 ANTIMICROBIALS AMPLYX PHARMACEUTICALS, INC. 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022040-A1 ANTIMICROBIALS PAM, MPO, OXA1L AR 2211/4885IDO1 1197/4885HSD11B1 3352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.